Peter van Galen

7.9k total citations · 4 hit papers
44 papers, 3.9k citations indexed

About

Peter van Galen is a scholar working on Molecular Biology, Cancer Research and Hematology. According to data from OpenAlex, Peter van Galen has authored 44 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Cancer Research and 12 papers in Hematology. Recurrent topics in Peter van Galen's work include Single-cell and spatial transcriptomics (13 papers), Cancer Genomics and Diagnostics (13 papers) and Acute Myeloid Leukemia Research (10 papers). Peter van Galen is often cited by papers focused on Single-cell and spatial transcriptomics (13 papers), Cancer Genomics and Diagnostics (13 papers) and Acute Myeloid Leukemia Research (10 papers). Peter van Galen collaborates with scholars based in United States, Canada and Spain. Peter van Galen's co-authors include John E. Dick, B Bernstein, Antonija Kreso, Kolja Eppert, Eric R. Lechman, Erno Wienholds, Steven Gallinger, Catherine O′Brien, Volker Hovestadt and Jon C. Aster and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Peter van Galen

42 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stem cell gene expression programs influence clinical outcome in human leukemia

2011 740 citations Kolja Eppert, Eric R. Lechman et al. Nature Medicine profile →
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

2019 613 citations Peter van Galen, Volker Hovestadt et al. profile →
Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer

2012 557 citations Antonija Kreso, Catherine O′Brien et al. Science profile →
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia

2022 150 citations Andy G.X. Zeng, Liqing Jin et al. Nature Medicine profile →

Peers

Countries citing papers authored by Peter van Galen

Since Specialization

Citations

This map shows the geographic impact of Peter van Galen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter van Galen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter van Galen more than expected).

Fields of papers citing papers by Peter van Galen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter van Galen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter van Galen. The network helps show where Peter van Galen may publish in the future.

Co-authorship network of co-authors of Peter van Galen

This figure shows the co-authorship network connecting the top 25 collaborators of Peter van Galen. A scholar is included among the top collaborators of Peter van Galen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter van Galen. Peter van Galen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibiting ferroptosis enhances ex vivo expansion of human haematopoietic stem cells 2025 ·Nature Cell Biology ·Lucrezia della Volpe, Andrew Lee, (unknown), Amy Deik, (unknown), Teng Gao, Chunjie Guo, (unknown), (unknown), Jorge D. Martin-Rufino, (unknown), (unknown), (unknown), Jiawei Zhao, Clary B. Clish, Peter van Galen, Vijay G. Sankaran	0
2	Cell populations in human breast cancers are molecularly and biologically distinct with age 2025 ·Nature Aging ·(unknown), (unknown), (unknown), Hanyun Zhang, Julia Chen, Milos Spasic, (unknown), (unknown), Rachel A. Freedman, Elizabeth A. Mittendorf, Alexander Swarbrick, Peter van Galen, Sandra S. McAllister	0
3	2025 – DECIPHERING CELL STATES AND GENEALOGIES OF HUMAN HEMATOPOIESIS 2024 ·Experimental Hematology ·Chen Weng, Fulong Yu, Dian Yang, (unknown), Peter van Galen, Jonathan S. Weissman, Vijay G. Sankaran	2
4	Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow 2024 ·Cancer Research Communications ·Milos Spasic, (unknown), (unknown), Elizabeth A. Mittendorf, Peter van Galen, Sandra S. McAllister	7
5	New frameworks for hematopoiesis derived from single-cell genomics 2024 ·Blood ·(unknown), Peter van Galen	6
6	Multiomic profiling of human clonal hematopoiesis reveals genotype and cell-specific inflammatory pathway activation 2024 ·Blood Advances ·J. Brett Heimlich, (unknown), Alyssa Parker, (unknown), Caitlyn Vlasschaert, (unknown), (unknown), (unknown), (unknown), Alexander J. Silver, Ayesha Ahmad, (unknown), (unknown), Ningning Hu, Peter van Galen, Michael R. Savona, Alexander G. Bick, P. Brent Ferrell	19
7	Chromatin complex dependencies reveal targeting opportunities in leukemia 2023 ·Nature Communications ·Fadi J. Najm, Peter C. DeWeirdt, (unknown), Samantha M. Bevill, Chadi A. El Farran, (unknown), Mudra Hegde, Amanda L. Waterbury, Brian B. Liau, Peter van Galen, John G. Doench, B Bernstein	7
8	WAT3R: recovery of T-cell receptor variable regions from 3′ single-cell RNA-sequencing 2022 ·Bioinformatics ·(unknown), Duncan M. Morgan, Erica A. K. DePasquale, J. Christopher Love, Felipe Prósper, Peter van Galen	7
9	CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response 2022 ·Leukemia ·Jonas S. Jutzi, Anna E. Marneth, (unknown), (unknown), Ángel Guerra-Moreno, Benjamin Rolles, Shruti Bhatt, Samuel A. Myers, Steven A. Carr, Yuning Hong, Olga Pozdnyakova, Peter van Galen, Fátima Al‐Shahrour, Anna S. Nam, Ann Mullally	13
10	Mitochondrial variant enrichment from high-throughput single-cell RNA sequencing resolves clonal populations 2022 ·Nature Biotechnology ·Tyler E. Miller, Caleb A. Lareau, Julia A. Verga, Erica A. K. DePasquale, Vincent Liu, (unknown), Katalin Sándor, Yajie Yin, Leif S. Ludwig, Chadi A. El Farran, Duncan M. Morgan, Ansuman T. Satpathy, Gabriel K. Griffin, Andrew A. Lane, J. Christopher Love, B Bernstein, Vijay G. Sankaran, Peter van Galen	74
11	Suppression of allograft rejection by regulatory B cells induced via TLR signaling 2022 ·JCI Insight ·(unknown), Qiang Fu, Guoli Huai, (unknown), Ji Lei, Lisa Kojima, Divyansh Agarwal, Peter van Galen, Shoko Kimura, Naoki Tanimine, (unknown), Heidi Yeh, Ali Naji, Charles G. Rickert, Christian LeGuern, James F. Markmann	12
12	A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia breakdown → 2022 ·Nature Medicine ·Andy G.X. Zeng, (unknown), Liqing Jin, Amanda Mitchell, Weihsu Claire Chen, Hussein A. Abbas, Michelle Chan‐Seng‐Yue, Véronique Voisin, Peter van Galen, Anne Tierens, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Naval Daver, P. Andrew Futreal, Mark D. Minden, James A. Kennedy, Jean Wang, John E. Dick	150
13	Systematic detection of m6A-modified transcripts at single-molecule and single-cell resolution 2021 ·Cell Reports Methods ·Kyung Lock Kim, Peter van Galen, Volker Hovestadt, Gilbert J. Rahme, Ekaterina N. Andreishcheva, (unknown), Elizabeth Gaskell, Daniel Jones, Efrat Shema, B Bernstein	10
14	Chromatin accessibility promotes hematopoietic and leukemia stem cell activity 2020 ·Nature Communications ·Lucía Cabal‐Hierro, Peter van Galen, Miguel A. Prado, (unknown), Katsuhiro Togami, Cody T. Mowery, João A. Paulo, Yingtian Xie, Paloma Cejas, Takashi Furusawa, Michael Bustin, Henry W. Long, David B. Sykes, Steven P. Gygi, Daniel Finley, B Bernstein, Andrew A. Lane	39
15	A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity 2019 ·Leukemia ·Muhammad Yassin, (unknown), (unknown), Peter van Galen, (unknown), B Bernstein, Maya Koren‐Michowitz, Jonathan Canaani, Arnon Nagler, Eric R. Lechman, John E. Dick, Erno Wienholds, Shai Izraeli, Michael Milyavsky	10
16	Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance 2016 ·Cell stem cell ·Brian B. Liau, Cem Sievers, Laura K. Donohue, Shawn Gillespie, William Flavahan, Tyler E. Miller, Andrew S. Venteicher, (unknown), Christopher D. Carey, Scott J. Rodig, Sarah J. Shareef, Fadi J. Najm, Peter van Galen, Hiroaki Wakimoto, Daniel P. Cahill, Jeremy N. Rich, Jon C. Aster, Mario L. Suvà, Anoop P. Patel, B Bernstein	354
17	A Multiplexed System for Quantitative Comparisons of Chromatin Landscapes 2015 ·Molecular Cell ·Peter van Galen, Aaron D. Viny, Oren Ram, Russell J.H. Ryan, Matthew J. Cotton, Laura K. Donohue, Cem Sievers, Yotam Drier, Brian B. Liau, Shawn Gillespie, Kaitlin M. Carroll, Michael B. Cross, Ross L. Levine, B Bernstein	78
18	Reduced Lymphoid Lineage Priming Promotes Human Hematopoietic Stem Cell Expansion 2014 ·Cell stem cell ·Peter van Galen, Antonija Kreso, Erno Wienholds, Elisa Laurenti, Kolja Eppert, Eric R. Lechman, Nathan Mbong, Karin G. Hermans, Stephanie M. Dobson, Craig April, Jian‐Bing Fan, John E. Dick	53
19	Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer breakdown → 2012 ·Science ·Antonija Kreso, Catherine O′Brien, Peter van Galen, Olga I. Gan, Faiyaz Notta, Andrew Brown, Karen Ng, Jing Ma, Erno Wienholds, Cyrille F. Dunant, Aaron Pollett, Steven Gallinger, John D. McPherson, Charles G. Mullighan, Darryl Shibata, John E. Dick	557
20	Attenuation of miR-126 Activity Expands HSC In Vivo without Exhaustion 2012 ·Cell stem cell ·Eric R. Lechman, Bernhard Gentner, Peter van Galen, Alice Giustacchini, Massimo Saini, Francesco Boccalatte, Hidefumi Hiramatsu, Umberto Restuccia, Angela Bachi, Véronique Voisin, Gary D. Bader, John E. Dick, Luigi Naldini	154

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact